Most Valuable CEO #8 – John C. Martin, Ph.D.
November 16 2011 by ChiefExecutive.net
This biopharmaceutical company has 14 marketed products and over 4200 employees on four continents. Gilead had almost $8 billion in revenues in 2010.
Gilead Sciences consistently ranks among top performers in the Wealth Creation Index. Among the consistent top performers, Mike Burdi, Applied Finance Group senior analyst, finds a common thread: “Do your customers care whether you stay in business? It’s one thing to say that one is customer-focused; most claim to be as a matter of course. But would your customers really miss not having access to what you offer?” For Gilead customers, that answer is yes.
|Score||2010 Score||% Change In Score||Market Value/Invested Capital||Three-Year EM||EM Change||Mgmt Quality|